The Case Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1826-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.case.edu/cancer
Clinical Trials
478
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (419 trials with phase data)• Click on a phase to view related trials
Artificial Intelligence-Powered Support For Quality Of Life Improvement In Participants With Cancer
- Conditions
- Cancer
- First Posted Date
- 2025-09-11
- Last Posted Date
- 2025-09-11
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT07167056
- Locations
- 🇺🇸
Cleveland Clinic Florida, Weston, Florida, United States
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
- Conditions
- Biliary Tract CancerBiliary Tract NeoplasmsCholangiocarcinomaGallbladder CancerGallbladder Carcinoma
- Interventions
- First Posted Date
- 2025-08-28
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 27
- Registration Number
- NCT07146646
- Locations
- 🇺🇸
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Musculoskeletal Cancers Remote Monitoring and Care
- Conditions
- OsteosarcomaMetastatic Bone Disease
- First Posted Date
- 2025-08-19
- Last Posted Date
- 2025-09-29
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT07129226
- Locations
- 🇺🇸
Case Comprehensive Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio, United States
Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain
- Conditions
- Pancreatic CancerRetroperitoneal Pain Syndrome
- First Posted Date
- 2025-08-12
- Last Posted Date
- 2025-08-12
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT07117032
- Locations
- 🇺🇸
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors
- Conditions
- Marker; Structural
- First Posted Date
- 2025-08-11
- Last Posted Date
- 2025-09-30
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 120
- Registration Number
- NCT07114614
- Locations
- 🇺🇸
Case Comprehensive Cancer Center, UH Rainbow Babies & Children's Hospital, Cleveland, Ohio, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 96
- Next